Mylan Reportedly Makes Bid for Meda
April 25 2014 - 11:50AM
Dow Jones News
U.S. drug maker Mylan Inc. (MYL) has made a renewed bid for
Swedish rival Meda AB in the last few days, The Financial Times
reported Friday, valuing the company at more than $9 billion.
The new SEK145 a share offer comes less than a month after
Mylan's SEK130 offer for Meda was rejected, according to people
familiar with the matter.
Full story at http://www.ft.com/intl/fastft
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024